Literature DB >> 31489225

Associations of the microbiome and esophageal disease.

Ikenna Okereke1, Catherine Hamilton1, Alison Wenholz1, Vikram Jala2, Thao Giang1, Sandy Reynolds1, Aaron Miller3, Richard Pyles3.   

Abstract

The incidence of esophageal diseases such as esophageal adenocarcinoma (EAC) and gastroesophageal reflux disease (GERD) have been increasing over the last 40 years. The esophageal microbiome appears to have a role in the development of some disease processes, and could also serve as markers of early diseases of the esophagus. A literature review was performed examining the role of the microbiome in the development of esophageal disease. In addition, the results of several studies and experiments were included in the review. Both EAC and GERD have increased in incidence over the last 40 years. Barrett's esophagus (BE) is a risk factor for EAC. Patients with BE appear to have a microbiome expression pattern distinct from patients without BE. The distinct pattern may be related to factors within the distal esophagus such as a more acidic environment, intraluminal stasis and other elements. It remains unclear whether the change in microflora leads to esophageal disease, or whether the disease process within the esophagus allows these particular organisms to experience overgrowth compared to other microflora. Patient factors such as body mass index (BMI), diet and geographic location also appear to affect the esophageal microbiome. There is an association with the esophageal microbiome and several esophageal diseases. Future studies should examine these correlations more closely. The distinct patterns may be able to serve as a marker of early disease, and possibly lead to a mechanism for the development of esophageal disease.

Entities:  

Keywords:  Microbiome; adenocarcinoma; gastroesophageal reflux disease (GERD)

Year:  2019        PMID: 31489225      PMCID: PMC6702393          DOI: 10.21037/jtd.2019.05.82

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  43 in total

Review 1.  Oral microbiome and oral and gastrointestinal cancer risk.

Authors:  Jiyoung Ahn; Calvin Y Chen; Richard B Hayes
Journal:  Cancer Causes Control       Date:  2012-01-22       Impact factor: 2.506

Review 2.  The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Philip L Molyneaux; Toby M Maher
Journal:  Eur Respir Rev       Date:  2013-09-01

Review 3.  Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

4.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

5.  Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Authors:  K L Blackett; S S Siddhi; S Cleary; H Steed; M H Miller; S Macfarlane; G T Macfarlane; J F Dillon
Journal:  Aliment Pharmacol Ther       Date:  2013-04-22       Impact factor: 8.171

6.  Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.

Authors:  Liying Yang; Xiaohua Lu; Carlos W Nossa; Fritz Francois; Richard M Peek; Zhiheng Pei
Journal:  Gastroenterology       Date:  2009-04-23       Impact factor: 22.682

Review 7.  The human gut microbiome and body metabolism: implications for obesity and diabetes.

Authors:  Sridevi Devaraj; Peera Hemarajata; James Versalovic
Journal:  Clin Chem       Date:  2013-02-11       Impact factor: 8.327

Review 8.  Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.

Authors:  Christopher P Wild; Laura J Hardie
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  The gut microbiota and irritable bowel syndrome: friend or foe?

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal; Kok-Ann Gwee; Siew C Ng; Eamonn M M Quigley
Journal:  Int J Inflam       Date:  2012-04-22
View more
  6 in total

Review 1.  Microbiome of the Aerodigestive Tract in Health and Esophageal Disease.

Authors:  Aws Hasan; Laith K Hasan; Bernd Schnabl; Madeline Greytak; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2020-11-24       Impact factor: 3.199

2.  Microbiota Detection Patterns Correlate With Presence and Severity of Barrett's Esophagus.

Authors:  Ikenna C Okereke; Aaron L Miller; Daniel C Jupiter; Catherine F Hamilton; Gabriel L Reep; Timothy Krill; Clark R Andersen; Richard B Pyles
Journal:  Front Cell Infect Microbiol       Date:  2021-02-23       Impact factor: 5.293

3.  The effects of smoking and drinking on the oral and esophageal microbiota of healthy people.

Authors:  Zhengqi Li; Yong Liu; Lizhou Dou; Yueming Zhang; Shun He; Deli Zhao; Wei Zhang; Guiqi Wang
Journal:  Ann Transl Med       Date:  2021-08

Review 4.  Faecal Microbiota in Infants and Young Children with Functional Gastrointestinal Disorders: A Systematic Review.

Authors:  Denise Hofman; Urszula Kudla; Mohamad Miqdady; Thi Viet Ha Nguyen; Sofía Morán-Ramos; Yvan Vandenplas
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

Review 5.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

6.  Effects of proton pump inhibitor use on the esophageal microbial community.

Authors:  Sadia Tasnim; Aaron L Miller; Daniel C Jupiter; Catherine F Hamilton; Gabriel L Reep; Timothy S Krill; Richard B Pyles; Ikenna C Okereke
Journal:  BMC Gastroenterol       Date:  2020-09-23       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.